These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8762872)

  • 1. Acyclovir prophylaxis of oral herpes virus during bone marrow transplantation.
    Epstein JB; Ransier A; Sherlock CH; Spinelli JJ; Reece D
    Eur J Cancer B Oral Oncol; 1996 May; 32B(3):158-62. PubMed ID: 8762872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
    Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
    Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyclovir prophylaxis for oral herpes simplex virus infection in patients with bone marrow transplants.
    Redding SW; Montgomery MT
    Oral Surg Oral Med Oral Pathol; 1989 Jun; 67(6):680-3. PubMed ID: 2544843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants.
    Ljungman P; de La Camara R; Milpied N; Volin L; Russell CA; Crisp A; Webster A;
    Blood; 2002 Apr; 99(8):3050-6. PubMed ID: 11929799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database.
    Badley AD; Seaberg EC; Porayko MK; Wiesner RH; Keating MR; Wilhelm MP; Walker RC; Patel R; Marshall WF; DeBernardi M; Zetterman R; Steers JL; Paya CV
    Transplantation; 1997 Jul; 64(1):66-73. PubMed ID: 9233703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group.
    Prentice HG; Gluckman E; Powles RL; Ljungman P; Milpied N; Fernandez Rañada JM; Mandelli F; Kho P; Kennedy L; Bell AR
    Lancet; 1994 Mar; 343(8900):749-53. PubMed ID: 7907729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients.
    Flechner SM; Avery RK; Fisher R; Mastroianni BA; Papajcik DA; O'Malley KJ; Goormastic M; Goldfarb DA; Modlin CS; Novick AC
    Transplantation; 1998 Dec; 66(12):1682-8. PubMed ID: 9884259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patients.
    Prentice HG
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():153-9. PubMed ID: 6313594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
    Winston DJ; Busuttil RW
    Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures.
    Miller CS; Cunningham LL; Lindroth JE; Avdiushko SA
    J Am Dent Assoc; 2004 Sep; 135(9):1311-8. PubMed ID: 15493396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection. The European Acyclovir for CMV Prophylaxis Study Group.
    Prentice HG; Gluckman E; Powles RL; Ljungman P; Milpied NJ; Camara R; Mandelli F; Kho P; Kennedy L; Bell AR
    Bone Marrow Transplant; 1997 Jan; 19(2):129-33. PubMed ID: 9116609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D; Scott LJ; Perry CM
    Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation.
    Meyers JD; Reed EC; Shepp DH; Thornquist M; Dandliker PS; Vicary CA; Flournoy N; Kirk LE; Kersey JH; Thomas ED
    N Engl J Med; 1988 Jan; 318(2):70-5. PubMed ID: 2827025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral prophylaxis of herpes infections using acyclovir following bone marrow transplantation: a clinical and clinico-pharmacological study].
    Ehninger G; Vallbracht A; Schüch K; Kumbier I; Dopfer R; Schmidt H; Ostendorf P
    Klin Wochenschr; 1986 Jun; 64(12):570-4. PubMed ID: 2426515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyclovir given as prophylaxis against oral ulcers in acute myeloid leukaemia: randomised, double blind, placebo controlled trial.
    Bergmann OJ; Ellermann-Eriksen S; Mogensen SC; Ellegaard J
    BMJ; 1995 May; 310(6988):1169-72. PubMed ID: 7767151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral acyclovir prophylactic treatment of herpes simplex infection after bone marrow transplantation.
    Gluckman E; Lotsberg J; Devergie A; Zhao XM; Melo R; Gomez-Morales M; Mazeron MC; Perol Y
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():161-7. PubMed ID: 6313595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer.
    Glenny AM; Fernandez Mauleffinch LM; Pavitt S; Walsh T
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006706. PubMed ID: 19160295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
    Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M
    Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
    Wagstaff AJ; Faulds D; Goa KL
    Drugs; 1994 Jan; 47(1):153-205. PubMed ID: 7510619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiviral prophylaxis].
    Graubner UB
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A69-76. PubMed ID: 11577365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.